We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

NeuroCDRD: Development Platform for Neurological Disease Therapies

News   Mar 31, 2017 | Original Story from the Centre for Drug Research and Development, Canada.

 
NeuroCDRD: Development Platform for Neurological Disease Therapies
 
 
 

RELATED ARTICLES

Screening System Designed To Detect Drugs That Block Drivers of Cancer Cell Growth

News

A new screening system leverages redundancy in an important component of a cell – nucleotide metabolism – to help detect new drugs that specifically and potently block processes that are essential for cancer cell growth.

READ MORE

Single Low-dose of Intravenous Ketamine Relieves Depressive Symptoms With Mild Side Effects

News

National Institutes of Health researchers found that a single, low-dose ketamine infusion was relatively free of side effects for patients with treatment-resistant depression.

READ MORE

Inflammation Linked to Mental Sluggishness

News

Scientists have uncovered a possible explanation for the mental sluggishness that often accompanies illness.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE